RepliCel Life Sciences

About:

RepliCel Life Sciences is a regenerative medicine company using cell therapy products for healing tendinosis, aging, and pattern baldness.

Website: http://www.replicel.com

Twitter/X: RepliCel

Top Investors: MainPointe Pharmaceuticals, YOFOTO

Description:

RepliCel is a regenerative medicine company with a focus on aesthetics and orthopedics. Its cell therapy products are tailor-made to restore cellular function rejuvenate aging or sun-damaged skin, regrow hair, and repair tendons. The company's dermal injection technology is designed to revolutionize aesthetic treatment outcomes.

Total Funding Amount:

$8.57M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Vancouver, British Columbia, Canada

Founded Date:

2010-01-01

Contact Email:

info(AT)replicel.com

Founders:

Kevin McElwee, Rolf Hoffmann

Number of Employees:

1-10

Last Funding Date:

2021-01-25

IPO Status:

Public

Industries:

© 2025 bioDAO.ai